These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18588432)

  • 21. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts.
    Rudiger A; Fischler M; Harpes P; Gasser S; Hornemann T; von Eckardstein A; Maggiorini M
    Int J Cardiol; 2008 May; 126(1):28-31. PubMed ID: 17477984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice.
    Buckley MG; Marcus NJ; Yacoub MH
    Clin Sci (Lond); 1999 Dec; 97(6):689-95. PubMed ID: 10585896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma.
    Belenky A; Smith A; Zhang B; Lin S; Despres N; Wu AH; Bluestein BI
    Clin Chim Acta; 2004 Feb; 340(1-2):163-72. PubMed ID: 14734208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension.
    Vizza CD; Letizia C; Petramala L; Badagliacca R; Poscia R; Zepponi E; Crescenzi E; Nona A; Benedetti G; Ferrante F; Sciomer S; Fedele F
    Regul Pept; 2008 Nov; 151(1-3):48-53. PubMed ID: 18796317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failure.
    Aspromonte N; Feola M; Milli M; Scardovi AB; Coletta C; Carbonieri E; Giovinazzo P; Di Giacomo T; Barro S; Rosso GL; Ceci V; Milani L; Valle R
    Diabet Med; 2007 Feb; 24(2):124-30. PubMed ID: 17257273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].
    Wang WJ; Zhang XM; Wang Q; Wen DM; Ouyang NL; Cui YL; Li F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):695-9. PubMed ID: 22169413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker.
    Mehra MR; Uber PA; Walther D; Vesely M; Wohlgemuth JG; Prentice J; Tayama D; Billingham M
    Circulation; 2006 Jul; 114(1 Suppl):I21-6. PubMed ID: 16820574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged stability of brain natriuretic peptide: importance for non-invasive assessment of cardiac function in clinical practice.
    Buckley MG; Marcus NJ; Yacoub MH; Singer DR
    Clin Sci (Lond); 1998 Sep; 95(3):235-9. PubMed ID: 9730841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between exercise capacity and brain natriuretic peptide in patients after cardiac surgery].
    Akashi YJ; Koike A; Omiya K; Osada N; Maeda T; Tajima A; Oikawa K; Aizawa T; Iinuma H; Fu LT; Itoh H
    J Cardiol; 2003 Aug; 42(2):67-74. PubMed ID: 12964516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure.
    Yandle TG; Richards AM; Gilbert A; Fisher S; Holmes S; Espiner EA
    J Clin Endocrinol Metab; 1993 Apr; 76(4):832-8. PubMed ID: 8473392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia.
    Win HK; Chang SM; Raizner M; Shah G; Al Basky F; Desai U; Plana JC; Mahmarian JJ; Quinones MA; Zoghbi WA
    Am Heart J; 2005 Oct; 150(4):695-700. PubMed ID: 16209968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure.
    Tang WH; Girod JP; Lee MJ; Starling RC; Young JB; Van Lente F; Francis GS
    Circulation; 2003 Dec; 108(24):2964-6. PubMed ID: 14662703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the diagnostic characteristics of two B-type natriuretic peptide point-of-care devices.
    Ro R; Thode HC; Taylor M; Gulla J; Tetrault E; Singer AJ
    J Emerg Med; 2011 Dec; 41(6):661-7. PubMed ID: 21620610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur.
    Lippi G; Fortunato A; Salvagno GL; Montagnana M; Soffiati G; Guidi GC
    J Clin Lab Anal; 2007; 21(5):293-7. PubMed ID: 17847103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
    Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
    Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic value of the B-type natriuretic peptide (BNP) in a cardiogeriatric department].
    Escande M
    Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):284-8. PubMed ID: 19833319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.